WO2003059374A3 - Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne - Google Patents

Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne Download PDF

Info

Publication number
WO2003059374A3
WO2003059374A3 PCT/EP2003/000240 EP0300240W WO03059374A3 WO 2003059374 A3 WO2003059374 A3 WO 2003059374A3 EP 0300240 W EP0300240 W EP 0300240W WO 03059374 A3 WO03059374 A3 WO 03059374A3
Authority
WO
WIPO (PCT)
Prior art keywords
dsnls
dimer
derived
binding domain
dna binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/000240
Other languages
English (en)
French (fr)
Other versions
WO2003059374A2 (de
Inventor
Thomas Meyer
Uwe Vinkemeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forschungsverbund Berlin FVB eV
Original Assignee
Forschungsverbund Berlin FVB eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forschungsverbund Berlin FVB eV filed Critical Forschungsverbund Berlin FVB eV
Priority to EP03702426A priority Critical patent/EP1467747B1/de
Priority to DE50308214T priority patent/DE50308214D1/de
Publication of WO2003059374A2 publication Critical patent/WO2003059374A2/de
Publication of WO2003059374A3 publication Critical patent/WO2003059374A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Die Erfindung betrifft die Verwendung von dimer-spezifischen Nuklear-Lokalisations-Signalpeptiden (dsNLS) abgeleitet aus der STAT DNA Bindungsdomäne zur Diagnose und/oder Therapie von mit ihnen in Zusammenhang stehenden Krankheiten und als Targetmoleküle zum Screening von pharmakologischen Wirkstoffen.
PCT/EP2003/000240 2002-01-17 2003-01-13 Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne Ceased WO2003059374A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03702426A EP1467747B1 (de) 2002-01-17 2003-01-13 Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne
DE50308214T DE50308214D1 (de) 2002-01-17 2003-01-13 Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10201791A DE10201791A1 (de) 2002-01-17 2002-01-17 Verwendung von dimer-spezifischen Nuclear-Lokalisations-Signalpeptiden (dsNLS) abgeleitet aus der STAT DNA Bindungsdomäne
DE10201791.3 2002-01-17

Publications (2)

Publication Number Publication Date
WO2003059374A2 WO2003059374A2 (de) 2003-07-24
WO2003059374A3 true WO2003059374A3 (de) 2004-03-25

Family

ID=7712476

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/000240 Ceased WO2003059374A2 (de) 2002-01-17 2003-01-13 Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne

Country Status (4)

Country Link
EP (2) EP1810685A1 (de)
AT (1) ATE373484T1 (de)
DE (2) DE10201791A1 (de)
WO (1) WO2003059374A2 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716622A (en) * 1995-01-06 1998-02-10 The Rockefeller University Functionally active regions of signal transducer and activators of transcription
US6087478A (en) * 1998-01-23 2000-07-11 The Rockefeller University Crystal of the N-terminal domain of a STAT protein and methods of use thereof
US6160092A (en) * 1998-05-29 2000-12-12 The Rockefeller University Crystal of the core portion of a signal transducer and activator of transcription (STAT)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716622A (en) * 1995-01-06 1998-02-10 The Rockefeller University Functionally active regions of signal transducer and activators of transcription
US6087478A (en) * 1998-01-23 2000-07-11 The Rockefeller University Crystal of the N-terminal domain of a STAT protein and methods of use thereof
US6160092A (en) * 1998-05-29 2000-12-12 The Rockefeller University Crystal of the core portion of a signal transducer and activator of transcription (STAT)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DARNELL JAMES E JR: "STATs and gene regulation.", SCIENCE (WASHINGTON D C), vol. 277, no. 5332, 1997, pages 1630 - 1635, XP002253444, ISSN: 0036-8075 *
FUKUZAWA MASASHI ET AL: "Tyrosine phosphorylation-independent nuclear translocation of a Dictyostelium STAT in response to DIF signaling.", MOLECULAR CELL, vol. 7, no. 4, April 2001 (2001-04-01), pages 779 - 788, XP008021628, ISSN: 1097-2765 *
YAN RIQIANG ET AL: "Identification of a Stat gene that functions in Drosophila development.", CELL, vol. 84, no. 3, 1996, pages 421 - 430, XP002253445, ISSN: 0092-8674 *

Also Published As

Publication number Publication date
ATE373484T1 (de) 2007-10-15
EP1467747B1 (de) 2007-09-19
DE50308214D1 (de) 2007-10-31
EP1810685A1 (de) 2007-07-25
EP1467747A2 (de) 2004-10-20
DE10201791A1 (de) 2003-08-07
WO2003059374A2 (de) 2003-07-24

Similar Documents

Publication Publication Date Title
WO2006127899A3 (en) (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
WO2003057134A3 (en) Specific binding agents of human angiopoietin-2
EP2336174A3 (de) Humane monoklonale Antikörper gegen Hendra- und Nipah-Viren
WO2004094475A3 (en) Tissue factor antibodies and uses thereof
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
WO2005056600A3 (en) Monoclonal antibodies that bind or neutralize dengue virus
DE60028970D1 (de) An her2 bindende peptidverbindungen
WO2007092640A3 (en) Antibodies that bind par-2
WO2006127757A3 (en) Interferon-igg fusion
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
WO2007075914A3 (en) Monoclonal antibodies against orthopoxviruses
WO2007056435A3 (en) Dynamin mediated diseases and associated methods and products
WO2006019982A3 (en) Pin1-modulating compounds and methods of use thereof
WO2005017187A3 (en) Methods for screening and identifying compounds
WO2002092765A3 (en) Novel telomerase inhibitors and uses therefor
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
WO2007087053A3 (en) Bmp-7 variant compositions, methods and uses
WO2001096873A3 (en) Method for identifying apoptosis-modified proteins
WO2003059374A3 (de) Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne
WO2007030708A3 (en) Antimicrobial adzymes and uses thereof
WO2006046134A3 (en) Method of screening by using conformation sensitive peptides
WO2008014054A3 (en) Bmp-7 variant compositions, methods and uses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003702426

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003702426

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2003702426

Country of ref document: EP